History
  • No items yet
midpage
Promedica Health System, Inc. v. Federal Trade Commission
749 F.3d 559
6th Cir.
2014
Read the full case

Background

  • Lucas County has four hospital providers; ProMedica is dominant with about 46.8% of the GAC market, St. Luke's about 11.5%, Mercy about 28.7%, UTMC about 13%.
  • ProMedica and St. Luke’s merged in August 2010, after FTC began investigating the transaction.
  • ALJ found the merger would substantially lessen competition and the Commission affirmed, ordering divestiture of St. Luke’s.
  • Markets: Lucas County GAC as the clustered primary+secondary services market, OB services as a separate market, with tertiary/quaternary excluded.
  • MCO bargaining dynamics before the merger showed ProMedica’s high prices and leverage; Hold Separate Agreement restricted actions pending FTC outcome; divestiture occurred as remedy.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Proper market definition for analyzing the merger ProMedica argues clustering is improper and that OB should be included. FTC/Commission supported clustering of primary+secondary (GAC) and separate OB market; OB/tertiary distinctions are justified. Correct market definition: cluster primary+secondary (GAC) and OB separate.
Applicability of HHI presumption in a unilateral-effects merger HHI presumption applies only to coordinated-effects cases, not unilateral-effects. HHI data are relevant even in unilateral-effects to assess market power and potential anticompetitive effect. HHI-based presumption upheld; merger likely to enhance market power.
Whether the merger is rebutted by efficiencies or other factors ProMedica failed to show consumer-benefiting efficiencies. Merger could yield efficiencies, but none shown here that offset anticompetitive effects. Presumption not rebutted; no efficiency defense undermines anticompetitive impact.
Appropriate remedy for found illegality Conduct remedy could be sufficient. Divestiture is preferred to preserve competition; conduct remedy insufficient. Divestiture affirmed as appropriate remedy.

Key Cases Cited

  • Brown Shoe Co. v. United States, 370 U.S. 294 (U.S. 1962) (market definition and grouping of similar markets; cluster analysis guidance)
  • Realcomp II, Ltd. v. FTC, 635 F.3d 815 (6th Cir. 2011) (substantial-evidence standard; market-power focus)
  • FTC v. Heinz Co., 246 F.3d 708 (D.C. Cir. 2001) (merger analysis and emphasis on market power and competitive effects)
  • Long Island Jewish Med. Ctr., 983 F. Supp. 121 (E.D.N.Y. 1997) (market definition and clustering considerations in hospital mergers)
  • United States v. Grinell Corp., 384 U.S. 563 (U.S. 1966) (package-deal/market for bundled services concept (historical reference))
  • H&R Block, Inc. v. United States, 833 F. Supp. 2d 36 (D.D.C. 2011) (unilateral effects framework and reliance on substitutability data)
Read the full case

Case Details

Case Name: Promedica Health System, Inc. v. Federal Trade Commission
Court Name: Court of Appeals for the Sixth Circuit
Date Published: Apr 22, 2014
Citation: 749 F.3d 559
Docket Number: 12-3583
Court Abbreviation: 6th Cir.